KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Net Income: 2009-2024

Historic Net Income for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to $561.8 million.

  • Jazz Pharmaceuticals' Net Income rose 16.77% to $251.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $565.9 million, marking a year-over-year increase of 21.63%. This contributed to the annual value of $561.8 million for FY2024, which is 34.45% up from last year.
  • Jazz Pharmaceuticals' Net Income amounted to $561.8 million in FY2024, which was up 34.45% from $417.8 million recorded in FY2023.
  • Jazz Pharmaceuticals' Net Income's 5-year high stood at $561.8 million during FY2024, with a 5-year trough of -$329.0 million in FY2021.
  • Its 3-year average for Net Income is $255.2 million, with a median of $417.8 million in 2023.
  • In the last 5 years, Jazz Pharmaceuticals' Net Income plummeted by 236.17% in 2021 and then surged by 295.13% in 2023.
  • Jazz Pharmaceuticals' Net Income (Yearly) stood at $241.6 million in 2020, then plummeted by 236.17% to -$329.0 million in 2021, then surged by 34.90% to -$214.1 million in 2022, then soared by 295.13% to $417.8 million in 2023, then surged by 34.45% to $561.8 million in 2024.